In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Laura Pizzi, Chief Science Officer, ISPOR—The Professional Society for Health Economics and Outcomes Research.
Questions:
00:00: Introduction
00:40: What is ISPOR’s vision for 2030?
03:39: Which stakeholders and sectors will be key to driving the Whole Health agenda?
10:19: What policy challenges is ISPOR actively addressing?
15:07: The balance between cost-effectiveness and affordability has always been challenging. Is ISPOR making this a core focus or will it remain a peripheral issue for healthcare researchers?
20:38: HEOR and Market Access have grown into distinct but connected fields. How is ISPOR working to improve their efficiency and alignment?
26:46: Is ISPOR involved in any work to demonstrate the value of HEOR?
35:09: Where does ISPOR stand on DEI policy, and what role is it playing in promoting inclusion in research?
42:10: Now that the initial hype around AI has settled, what are the 2–3 key areas ISPOR is focusing on to guide the conversation?
46:33: Rapid Fire Questions
Laura Pizzi
Chief Science Officer, ISPOR—The Professional Society for Health Economics and Outcomes Research
Dr Laura Pizzi is the chief science officer for ISPOR—The Professional Society for Health Economics and Outcomes Research. ISPOR is the leading global professional society for health economics and outcomes research (HEOR). In her role, Dr Pizzi provides strategic scientific leadership and oversees the organization’s major initiatives, including the development of ISPOR’s science strategy, content priorities, and global initiatives such as Special Interest Groups, Patient Council, regional Patient Representative Roundtables, Health Technology Assessment (HTA) Roundtables, and the organization’s AI and Digital Health member initiatives. Her team is also responsible for engaging with global healthcare authorities to support the use of HEOR in healthcare decision making. With a strong passion for education, Dr Pizzi co-led the development of ISPOR ’s first Health Economics and Outcomes Research Competency Framework, which outlines the core knowledge and skills essential to the HEOR profession.
Dr Pizzi brings more than 25 years of academic and research expertise to ISPOR. She has led multidisciplinary teams of methodologists, statisticians, and clinicians in designing and conducting cost and outcomes analyses for both pharmacologic therapies and nonpharmacologic interventions. Much of her work has focused on improving the quality of and access to treatments for older adults in underrepresented communities for diseases of aging such as dementia, diabetes, chronic vision diseases, and vaccine-preventable illness. Her achievements include leading health economic analyses for numerous multicenter clinical trials, testifying before the US House of Representatives Committee on Ways and Means on Medicare spending, authoring a textbook on economic evaluation, and publishing more than 100 peer-reviewed manuscripts and 120 research presentations.
In addition to her leadership role at ISPOR, Dr Pizzi serves as research professor at Rutgers University, Ernest Mario School of Pharmacy. Her academic career has centered on advancing the science of health economics, influencing healthcare policy, and training the next generation of HEOR professionals.
","author_name":"The Evidence Base"}